These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 36387247)

  • 1. Regulation, genomics, and clinical characteristics of cuproptosis regulators in pan-cancer.
    Zhou C; Li C; Zheng Y; Huang X
    Front Oncol; 2022; 12():934076. PubMed ID: 36387247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive analysis and validation of cuproptosis-associated genes across cancers: Overall survival, the tumor microenvironment, stemness scores, and drug sensitivity.
    Liu J; Lu Y; Dai Y; Shen Y; Zeng C; Liu X; Yu H; Deng J; Lu W
    Front Genet; 2022; 13():939956. PubMed ID: 36105090
    [No Abstract]   [Full Text] [Related]  

  • 3. Cuproptosis-Related Genes MTF1 and LIPT1 as Novel Prognostic Biomarker in Acute Myeloid Leukemia.
    Li Y; Kan X
    Biochem Genet; 2024 Apr; 62(2):1136-1159. PubMed ID: 37561332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pan-cancer genetic analysis of cuproptosis and copper metabolism-related gene set.
    Liu H; Tang T
    Front Oncol; 2022; 12():952290. PubMed ID: 36276096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pan-cancer profiles of the cuproptosis gene set.
    Liu H
    Am J Cancer Res; 2022; 12(8):4074-4081. PubMed ID: 36119826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel cuproptosis-related gene signature of prognosis and immune microenvironment in head and neck squamous cell carcinoma cancer.
    Jiang X; Ke J; Jia L; An X; Ma H; Li Z; Yuan W
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):203-218. PubMed ID: 36376617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and Validation of Cuproptosis-Related Prognostic Signature and Associated Regulatory Axis in Uterine Corpus Endometrial Carcinoma.
    Chen Y
    Front Genet; 2022; 13():912037. PubMed ID: 35937995
    [No Abstract]   [Full Text] [Related]  

  • 8. Comprehensive analysis of cuproptosis genes and cuproptosis-related genes as prognosis factors in esophageal squamous cell carcinoma.
    Wu Z; Huang Z; Zhou X; Gao C; Peng Z; Zheng X; Zhang Y; Du Z; Wu B
    Genomics; 2023 Nov; 115(6):110732. PubMed ID: 37866660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Database Mining Detected a Cuproptosis-Related Prognostic Signature and a Related Regulatory Axis in Breast Cancer.
    Jiang B; Zhu H; Feng W; Wan Z; Qi X; He R; Xie L; Li Y
    Dis Markers; 2022; 2022():9004830. PubMed ID: 36312586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of cuproptosis identified immune microenvironment and prognosis in acute myeloid leukemia.
    Luo D; Liu S; Luo J; Chen H; He Z; Gao Z; Wen Z; Liu X; Xu N
    Clin Transl Oncol; 2023 Aug; 25(8):2393-2407. PubMed ID: 36826709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cuproptosis-related gene signature and associated regulatory axis in stomach adenocarcinoma based on bioinformatics analysis.
    Ding D; Wang D; Qin Y
    Medicine (Baltimore); 2023 Jul; 102(30):e34230. PubMed ID: 37505170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression Profiles of Cuproptosis-Related Genes Determine Distinct Subtypes of Pancreatic Ductal Adenocarcinoma.
    Chen Y; Zou X; Ma M; Liu Y; Wang R; Dai Z; Tashiheng Y; Yan Y; Yu X; Wang X; Liu C; Lin X; Cheng H
    Curr Oncol; 2023 Jan; 30(2):1648-1662. PubMed ID: 36826087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel cuproptosis-related prognostic gene signature in adrenocortical carcinoma.
    Gao W; He X; Huangfu Q; Xie Y; Chen K; Sun C; Wei J; Wang B
    J Clin Lab Anal; 2023 Nov; 37(21-22):e24981. PubMed ID: 37997497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pan-cancer integrated bioinformatics analysis reveals cuproptosis related gene FDX1 is a potential prognostic and immunotherapeutic biomarker for lower-grade gliomas.
    Huang W; Wu Y; Zhu J; Luo N; Wang C; Liu S; Cheng Z
    Front Mol Biosci; 2023; 10():963639. PubMed ID: 36825202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of GLS as a cuproptosis-related diagnosis gene in acute myocardial infarction.
    Liu Z; Wang L; Xing Q; Liu X; Hu Y; Li W; Yan Q; Liu R; Huang N
    Front Cardiovasc Med; 2022; 9():1016081. PubMed ID: 36440046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of cuproptosis-related genes in prognosis and immune infiltration in grade 4 diffuse gliomas.
    Liu H; Bao X; Zeng Z; Liu W; Li M
    Heliyon; 2024 Apr; 10(7):e29212. PubMed ID: 38633656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cuproptosis-related genes signature and validation of differential expression and the potential targeting drugs in temporal lobe epilepsy.
    Yang X; Zhang X; Shen K; Wang Z; Liu G; Huang K; He Z; Li Y; Hou Z; Lv S; Zhang C; Yang H; Liu S; Ke Y
    Front Pharmacol; 2023; 14():1033859. PubMed ID: 37435496
    [No Abstract]   [Full Text] [Related]  

  • 18. A novel prognostic signature of cuproptosis-related genes and the prognostic value of FDX1 in gliomas.
    Zhu H; Wan Q; Tan J; Ouyang H; Pan X; Li M; Zhao Y
    Front Genet; 2022; 13():992995. PubMed ID: 36579333
    [No Abstract]   [Full Text] [Related]  

  • 19. A Novel Cuproptosis-Related Prognostic Gene Signature and Validation of Differential Expression in Clear Cell Renal Cell Carcinoma.
    Bian Z; Fan R; Xie L
    Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and molecular landscape of cuproptosis signature-related molecular subtype in gastric cancer.
    Chong W; Ren H; Chen H; Xu K; Zhu X; Liu Y; Sang Y; Li H; Liu J; Ye C; Shang L; Jing C; Li L
    Imeta; 2024 Jun; 3(3):e190. PubMed ID: 38898987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.